Bioinformatic analysis of molecular characteristics and oncogenicfeatures of CARD14 in human cancer

dc.contributor.authorBespalov, Daniil
dc.contributor.authorPino, Dayana
dc.contributor.authorVidal-Guirao, Sònia
dc.contributor.authorFranquesa, Júlia
dc.contributor.authorLopez-Ramajo, Daniel
dc.contributor.authorFilgaira Enri, Ingrid
dc.contributor.authorWan, Lin
dc.contributor.authorO'Sullivan, Paul A.
dc.contributor.authorLey, Steven C.
dc.contributor.authorForcales Fernàndez, Sonia-Vanina
dc.contributor.authorRojas, Juan José
dc.contributor.authorIzquierdo Serra, Mercè
dc.contributor.authorSoler Prat, Concepció
dc.contributor.authorManils Pacheco, Joan
dc.date.accessioned2024-11-15T19:01:32Z
dc.date.available2024-11-15T19:01:32Z
dc.date.issued2024-10-03
dc.date.updated2024-11-15T19:01:32Z
dc.description.abstractAberrant caspase recruitment domain family member 14 (CARD14) signaling has been strongly associated with inflammatory skin conditions. CARD14 acts as a scaffold protein, ultimately activating the transcription factor NF-KB. Although primarily studied in the context of inflammation, recent research has suggested its potential implications in tumorigenesis. In this study, we gathered The Cancer Genome Atlas (TCGA) tumor data to gauge the involvement of CARD14 in cancer, including genetic alterations, expression patterns, survival correlations, immune cell infiltration and functional interactions across diverse cancer types. We found heightened CARD14 expression in most tumors and there was a significant correlation between CARD14 expression and the prognosis of patients for certain tumors. For instance, patients with higher CARD14 expression had a better prognosis in sarcoma, lung, cervix and head and neck cancers. Moreover, CARD14 expression positively correlated with neutrophil infiltration in most of the cancer types analyzed. Finally, enrichment analysis showed that epithelial development and differentiation pathways were involved in the functional mechanism of CARD14. Our results show that CARD14 may have the potential to become a prognostic biomarker in several cancers, hence, further prospective studies will be required for its validation.
dc.format.extent14 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec751543
dc.identifier.issn2045-2322
dc.identifier.pmid39362963
dc.identifier.urihttps://hdl.handle.net/2445/216541
dc.language.isoeng
dc.publisherNature Publishing Group
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/s41598-024-74565-4
dc.relation.ispartofScientific Reports, 2024, vol. 14
dc.relation.urihttps://doi.org/10.1038/s41598-024-74565-4
dc.rightscc by-nc-nd (c) Bespalov, D. et al., 2024
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationMarcadors bioquímics
dc.subject.classificationBiologia computacional
dc.subject.classificationExpressió gènica
dc.subject.otherBiochemical markers
dc.subject.otherComputational biology
dc.subject.otherGene expression
dc.titleBioinformatic analysis of molecular characteristics and oncogenicfeatures of CARD14 in human cancer
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
870029.pdf
Mida:
3.32 MB
Format:
Adobe Portable Document Format